Upgrades
Alliance Global Partners upgraded the previous rating for KNOT Offshore Partners LP (NYSE:KNOP) from Neutral to Buy. KNOT Offshore Partners earned $0.04 in the first quarter, compared to $0.79 in the year-ago quarter. The stock has a 52-week-high of $18.67 and a 52-week-low of $4.28. At the end of the last trading period, KNOT Offshore Partners closed at $4.80.
Ladenburg Thalmann upgraded the previous rating for Advaxis Inc (OTC:ADXS) from Neutral to Buy. The stock has a 52-week-high of $7.20 and a 52-week-low of $0.65. At the end of the last trading period, Advaxis closed at $0.85.
For ChargePoint Holdings Inc (NYSE:CHPT), B of A Securities upgraded the previous rating of Neutral to Buy. ChargePoint Hldgs earned $0.13 in the fourth quarter, compared to $0.17 in the year-ago quarter. The current stock performance of ChargePoint Hldgs shows a 52-week-high of $19.92 and a 52-week-low of $7.82. Moreover, at the end of the last trading period, the closing price was at $8.49.
For Elevation Oncology Inc (NASDAQ:ELEV), SVB Securities upgraded the previous rating of Market Perform to Outperform. For the first quarter, Elevation Oncology had an EPS of $0.50, compared to year-ago quarter EPS of $0.74. The stock has a 52-week-high of $5.89 and a 52-week-low of $0.72. At the end of the last trading period, Elevation Oncology closed at $5.02.
According to Vertical Research, the prior rating for Heico Corp (NYSE:HEI) was changed from Hold to Buy. For the second quarter, Heico had an EPS of $0.76, compared to year-ago quarter EPS of $0.62. The current stock performance of Heico shows a 52-week-high of $180.59 and a 52-week-low of $127.17. Moreover, at the end of the last trading period, the closing price was at $159.30.
According to Jefferies, the prior rating for Ford Motor Co (NYSE:F) was changed from Hold to Buy. Ford Motor earned $0.63 in the first quarter, compared to $0.38 in the year-ago quarter. The stock has a 52-week-high of $16.68 and a 52-week-low of $10.62. At the end of the last trading period, Ford Motor closed at $12.09.
Roth MKM upgraded the previous rating for Boston Beer Co Inc (NYSE:SAM) from Neutral to Buy. Boston Beer Co earned $0.73 in the first quarter, compared to $0.16 in the year-ago quarter. The stock has a 52-week-high of $420.50 and a 52-week-low of $287.01. At the end of the last trading period, Boston Beer Co closed at $317.85.
For Constellation Brands Inc (NYSE:STZ), Roth MKM upgraded the previous rating of Neutral to Buy. For the fourth quarter, Constellation Brands had an EPS of $1.98, compared to year-ago quarter EPS of $2.37. At the moment, the stock has a 52-week-high of $261.23 and a 52-week-low of $208.12. Constellation Brands closed at $232.88 at the end of the last trading period.
For Equitrans Midstream Corp (NYSE:ETRN), RBC Capital upgraded the previous rating of Sector Perform to Outperform. For the first quarter, Equitrans Midstream had an EPS of $0.22, compared to year-ago quarter EPS of $0.14. The current stock performance of Equitrans Midstream shows a 52-week-high of $9.89 and a 52-week-low of $4.60. Moreover, at the end of the last trading period, the closing price was at $6.09.
For Coinbase Global Inc (NASDAQ:COIN), Atlantic Equities upgraded the previous rating of Neutral to Overweight. For the first quarter, Coinbase Glb had an EPS of $0.34, compared to year-ago quarter EPS of $1.98. At the moment, the stock has a 52-week-high of $116.30 and a 52-week-low of $31.55. Coinbase Glb closed at $56.92 at the end of the last trading period.
According to BMO Capital, the prior rating for Alliant Energy Corp (NASDAQ:LNT) was changed from Market Perform to Outperform. In the first quarter, Alliant Energy showed an EPS of $0.65, compared to $0.77 from the year-ago quarter. The current stock performance of Alliant Energy shows a 52-week-high of $64.59 and a 52-week-low of $47.23. Moreover, at the end of the last trading period, the closing price was at $50.97.
See all analyst ratings upgrades.
Downgrades
According to Macquarie, the prior rating for NeoGames SA (NASDAQ:NGMS) was changed from Outperform to Neutral. In the first quarter, NeoGames showed an EPS of $0.20, compared to $0.03 from the year-ago quarter. The current stock performance of NeoGames shows a 52-week-high of $27.77 and a 52-week-low of $10.85. Moreover, at the end of the last trading period, the closing price was at $27.27.
See all analyst ratings downgrades.
Initiations
With a Buy rating, Jefferies initiated coverage on Acelyrin Inc (NASDAQ:SLRN). The price target seems to have been set at $31.00 for Acelyrin. The stock has a 52-week-high of $25.84 and a 52-week-low of $19.06. At the end of the last trading period, Acelyrin closed at $19.27.
With an Outperform rating, Northland Capital Markets initiated coverage on Tigo Energy Inc (NASDAQ:TYGO). The price target seems to have been set at $20.00 for Tigo Energy. The stock has a 52-week-high of $21.33 and a 52-week-low of $10.40. At the end of the last trading period, Tigo Energy closed at $10.76.
Craig-Hallum initiated coverage on Heritage Global Inc (NASDAQ:HGBL) with a Buy rating. The price target for Heritage Glb is set to $6.00. Heritage Glb earned $0.08 in the first quarter, compared to $0.02 in the year-ago quarter. The stock has a 52-week-high of $3.81 and a 52-week-low of $1.15. At the end of the last trading period, Heritage Glb closed at $3.81.
UBS initiated coverage on Kenvue Inc (NYSE:KVUE) with a Neutral rating. The price target for Kenvue is set to $28.00. At the moment, the stock has a 52-week-high of $27.80 and a 52-week-low of $25.25. Kenvue closed at $26.30 at the end of the last trading period.
RBC Capital initiated coverage on Viridian Therapeutics Inc (NASDAQ:VRDN) with an Outperform rating. The price target for Viridian Therapeutics is set to $44.00. Viridian Therapeutics earned $1.61 in the first quarter, compared to $0.98 in the year-ago quarter. At the moment, the stock has a 52-week-high of $39.00 and a 52-week-low of $9.84. Viridian Therapeutics closed at $23.73 at the end of the last trading period.
With a Buy rating, B of A Securities initiated coverage on Kenvue Inc (NYSE:KVUE). The price target seems to have been set at $30.00 for Kenvue. The current stock performance of Kenvue shows a 52-week-high of $27.80 and a 52-week-low of $25.25. Moreover, at the end of the last trading period, the closing price was at $26.30.
With a Equal-Weight rating, Morgan Stanley initiated coverage on Steris PLC (NYSE:STE). The price target seems to have been set at $206.00 for Steris. In the fourth quarter, Steris showed an EPS of $2.30, compared to $2.04 from the year-ago quarter. The current stock performance of Steris shows a 52-week-high of $235.95 and a 52-week-low of $159.88. Moreover, at the end of the last trading period, the closing price was at $200.44.
Morgan Stanley initiated coverage on The Cooper Companies Inc (NYSE:COO) with a Equal-Weight rating. The price target for Cooper Companies is set to $410.00. Cooper Companies earned $2.90 in the first quarter, compared to $3.24 in the year-ago quarter. The current stock performance of Cooper Companies shows a 52-week-high of $395.20 and a 52-week-low of $244.53. Moreover, at the end of the last trading period, the closing price was at $369.39.
RBC Capital initiated coverage on Kenvue Inc (NYSE:KVUE) with an Outperform rating. The price target for Kenvue is set to $29.00. The stock has a 52-week-high of $27.80 and a 52-week-low of $25.25. At the end of the last trading period, Kenvue closed at $26.30.
With a Buy rating, Needham initiated coverage on Confluent Inc (NASDAQ:CFLT). The price target seems to have been set at $35.00 for Confluent. Confluent earned $0.09 in the first quarter, compared to $0.19 in the year-ago quarter. The current stock performance of Confluent shows a 52-week-high of $34.39 and a 52-week-low of $16.60. Moreover, at the end of the last trading period, the closing price was at $28.71.
William Blair initiated coverage on Vertex Pharmaceuticals Inc (NASDAQ:VRTX) with an Outperform rating. In the first quarter, Vertex Pharmaceuticals showed an EPS of $3.05, compared to $3.52 from the year-ago quarter. The stock has a 52-week-high of $354.46 and a 52-week-low of $243.25. At the end of the last trading period, Vertex Pharmaceuticals closed at $329.99.
TD Cowen initiated coverage on Acelyrin Inc (NASDAQ:SLRN) with an Outperform rating. At the moment, the stock has a 52-week-high of $25.84 and a 52-week-low of $19.06. Acelyrin closed at $19.27 at the end of the last trading period.
With a Neutral rating, Exane BNP Paribas initiated coverage on Kenvue Inc (NYSE:KVUE). The price target seems to have been set at $28.00 for Kenvue. At the moment, the stock has a 52-week-high of $27.80 and a 52-week-low of $25.25. Kenvue closed at $26.30 at the end of the last trading period.
Citigroup initiated coverage on Kenvue Inc (NYSE:KVUE) with a Neutral rating. The price target for Kenvue is set to $28.00. At the moment, the stock has a 52-week-high of $27.80 and a 52-week-low of $25.25. Kenvue closed at $26.30 at the end of the last trading period.
With an Overweight rating, Piper Sandler initiated coverage on Acelyrin Inc (NASDAQ:SLRN). The price target seems to have been set at $68.00 for Acelyrin. The stock has a 52-week-high of $25.84 and a 52-week-low of $19.06. At the end of the last trading period, Acelyrin closed at $19.27.
With a Equal-Weight rating, Barclays initiated coverage on Paylocity Holding Corp (NASDAQ:PCTY). The price target seems to have been set at $199.00 for Paylocity Holding. For the third quarter, Paylocity Holding had an EPS of $1.74, compared to year-ago quarter EPS of $1.22. The stock has a 52-week-high of $275.48 and a 52-week-low of $152.12. At the end of the last trading period, Paylocity Holding closed at $172.61.
With a Hold rating, Deutsche Bank initiated coverage on Kenvue Inc (NYSE:KVUE). The price target seems to have been set at $27.00 for Kenvue. At the moment, the stock has a 52-week-high of $27.80 and a 52-week-low of $25.25. Kenvue closed at $26.30 at the end of the last trading period.
Goldman Sachs initiated coverage on Kenvue Inc (NYSE:KVUE) with a Neutral rating. The price target for Kenvue is set to $29.00. At the moment, the stock has a 52-week-high of $27.80 and a 52-week-low of $25.25. Kenvue closed at $26.30 at the end of the last trading period.
With an Overweight rating, JP Morgan initiated coverage on Kenvue Inc (NYSE:KVUE). The price target seems to have been set at $29.00 for Kenvue. The stock has a 52-week-high of $27.80 and a 52-week-low of $25.25. At the end of the last trading period, Kenvue closed at $26.30.
See all analyst ratings initiations.
